The Saint Agnes Heart Failure Center
|
|
- Rose Wilkinson
- 6 years ago
- Views:
Transcription
1 The Saint Agnes Heart Failure Center An NP and RN led program to engage patients in self-care Jae Patton, CRNP Deborah Hefty, RN,CHFN Theresa Kasper, RN, CHFN Heart Failure Center Saint Agnes Hospital, Baltimore
2 2 Presenters have no disclosures
3 Session Objectives Session attendees will be able to list three strategies for reducing heart failure readmissions Session attendees will be able to discuss the importance of an individualized approach to patient engagement in their own selfmanagement 3
4 Heart Failure: the problem > 5 million Americans diagnosed, $32 Billion/yr # 1 Cause of hospitalization in patients >65 # 1 diagnosis associated with 30 day readmissions 4
5 Heart Failure Disease Trajectory 50% mortality in 5 years 5
6 Systolic vs Diastolic 6
7 Definition of Heart Failure Classification I. Heart Failure with Reduced Ejection Fraction (HFrEF) Ejection Description Fraction 40% Also referred to as systolic HF. Randomized clinical trials have mainly enrolled patients with HFrEF and it is only in these patients that efficacious therapies have been demonstrated to date. II. Heart Failure with Preserved Ejection Fraction (HFpEF) 50% Also referred to as diastolic HF. Several different criteria have been used to further define HFpEF. The diagnosis of HFpEF is challenging because it is largely one of excluding other potential noncardiac causes of symptoms suggestive of HF. To date, efficacious therapies have not been identified. a. HFpEF, Borderline 41% to 49% These patients fall into a borderline or intermediate group. Their characteristics, treatment patterns, and outcomes appear similar to those of patient with HFpEF. b. HFpEF, Improved >40% It has been recognized that a subset of patients with HFpEF previously had HFrEF. These patients with improvement or recovery in EF may be clinically distinct from those with persistently preserved or reduced EF. Further research is needed to better characterize these patients.
8 Classification of Heart Failure A B C D ACCF/AHA Stages of HF At high risk for HF but without structural heart disease or symptoms of HF. Structural heart disease but without signs or symptoms of HF. Structural heart disease with prior or current symptoms of HF. Refractory HF requiring specialized interventions. None I I II III IV NYHA Functional Classification No limitation of physical activity. Ordinary physical activity does not cause symptoms of HF. No limitation of physical activity. Ordinary physical activity does not cause symptoms of HF. Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in symptoms of HF. Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms of HF. Unable to carry on any physical activity without symptoms of HF, or symptoms of HF at rest.
9 Heart Failure Admissions/Readmissions Worsening of disease, co-morbid diagnoses Complexities of Self Care diet and medications are complicated More difficult in patients with poor social determinants of health Financial, social, family responsibilities, substance abuse, health literacy all potential barriers to Self Care 9
10 What works?? Multidisciplinary team care! multidisciplinary heart failure clinic interventions currently have the best evidence for reducing allcause readmissions and mortality up to 6 months after an index hospitalization for persons with heart failure. Feltner C, et al. Transitional care interventions to prevent readmissions for persons with heart failure. Ann Intern Med. 2014; (160):
11 11 The Saint Agnes Heart Failure Center : A multidisciplinary disease management clinic serving patients since 2005
12 Saint Agnes HFC: Our patients 44% reside in Health Enterprise Zone zip codes (West Baltimore, often poor social determinants of health, higher death rates from CV disease) 64% African American Age range from 20s-90s 12
13 Saint Agnes HFC: Patients with range of socioeconomic backgrounds Poorest of the poor, active drug users, homeless and marginally housed Working class/ working poor patients who do physical labor, often marginally insured Wealthy (small population) often our oldest patients (80s and 90s) 13
14 Our team Kabir Yousuf, Medical Director and Champion Allison Mackenzie, Administrative Director Jae Patton, NP supervisor Kelly Gayed Heart Failure Coordinator, Clinic Nurse Practitioner Heart Failure RNs Deborah Hefty, Theresa Kasper, Jessica Harrison Nurse Navigator open position Front office Staff - Shannon Crosland, secretary; Rashawnda Robinson, PSR/MA And most recently our Chaplain, Sister Louise Busby 14
15 Physician Champion and Medical Director Kabir Yousuf, MD Important to establish trust with other physicians in our hospital community Expert medical back-up while NPs and RNs run the daily operations, a medical director with expertise in HF allows us to take sicker patients 15
16 Heart Failure Coordinator Bridge to Inpatients Kelly Gayed, CRNP Role originally started as Core Measures sheriff now Identifies HF patients while they re in-house not always clear on admit (Abstracted list daily of patients with HF, other diagnoses) Identifies high risk inpatients 30 day readmits, high utilizers, newly diagnosed Ensures inpatient staff have the tools they need for bedside teaching Participates in care plan development on High Utilizer Task Force 16
17 Heart Failure Nurse Navigator - Patients Bridge to Follow Up Role originally developed to address 30 day readmissions Evolved to focus on barriers to care that result in poor patient outcomes Works with Coordinator to identify inpatients with heart failure Bridges patients who qualify to Heart Failure Center Makes phone contact with ALL patients discharged with heart failure diagnosis to ensure they have appropriate follow up Follows these patients for a minimum of 30 days post discharge Identifies resources for HFC patients with significant barriers to care 17
18 18 The HFC Vision: Keeping Heart Failure Patients at Home, Improving their Quality of Life through Positive Engagement
19 Compliance? Adherence? We like engagement! A positive working relationship with the health care provider may result in improved adherence. Wu JR et al. Factors influencing medication adherence in patients with heart failure. Heart Lung 2008;37:8-16. The working alliance is important in medical treatment, as it is associated with patient adherence and satisfaction. Fuertes JN et al. The physician-patient working alliance. Patient Education and Counseling 2007; 66: Several studies have documented that more highly activated patients consistently report more positive care experiences. Hibbard JH, Greene J. What the evidence shows about patient activation: Better health outcomes and care experiences; fewer data on costs. Health Affairs 2013; 32:
20 HFC Team: our day Staffed by NP/RN - Medical director as back up Checklist Team Rounds all hands on deck! Scheduled visits medication titration and follow up, patient education Preventing PAUs ED admit prevention program, phone triage/ diuretic titration, or urgent diuresis if needed 20
21 EF: % Ischemic Non-Isch Diastolic Other Last Appt: / / Summary: BP HR Recent ED/Hosp: Check-In Insurance No Concerns Concerns Identified Notes/Comments Triage Labs In House Send Out Check Today Provider Patient Goals Identified Needs Update SCD Risk ICD Reeval EF No ICD N/A Beta Blocker At Goal/Maxed Start/Up Titrate On Hold ACE/ARB At Goal/Maxed Start/Up Titrate On Hold Ald Antagonist At Goal/Maxed Start/Up Titrate On Hold Bidil/Combo At Goal/Maxed Start/Up Titrate On Hold Diuretic Lasix Bumex Metolazone Cardiac Rehab Participating Refer Completed N/A Advanced Care Plan Today: Has AD Scanned? Y / N No AD Video Today Palliative C/S RN Education Low Na Diet Symptoms Meds/Pill Box Activity Fluid Goal Notes: Navigator Social Transport Medication Food Other Follow-Up Primary Care Cardiology Mental Health Other
22 Medical Management: the NPs Guideline Directed Medical Therapy (GDMT): getting Heart Failure core medications to goal *quickly* and safely ACE inhibitors, ARBs, Entresto Beta blockers (Carvedilol, Metoprolol succinate) Spironolactone Bidil in African Americans (already on ACE I, beta blocker) 22
23 Medical Therapy for Stage C HFrEF: Magnitude of Benefit Demonstrated in RCTs GDMT RR Reduction in Mortality NNT for Mortality Reduction (Standardized to 36 mo) RR Reduction in HF Hospitalizations ACE inhibitor or ARB 17% 26 31% Beta blocker 34% 9 41% Aldosterone antagonist 30% 6 35% Hydralazine/nitrate 43% 7 33%
24 Sacubitril/Valsartan: A few words about the new kid on the block 24
25 Titrate to patient symptoms Don t be afraid of low blood pressures particularly in systolic heart failure patients! 25
26 Pharmacologic Treatment for Stage C HFrEF
27 Medical Management: the NPs GDMT: Assessment of Sudden Cardiac Death risk - Ischemics 6 weeks - Non-ischemics months Referral for re-evaluation of ejection fraction, need for ICD or CRT-D device 27
28 Device Therapy for Stage C HFrEF (cont.) Recommendations COR LOE ICD therapy is recommended for primary prevention of SCD in selected patients with HFrEF at least 40 days post-mi with LVEF 35%, and NYHA class II or III symptoms on chronic GDMT, who are expected to live 1 year* I A CRT is indicated for patients who have LVEF 35%, sinus rhythm, LBBB with a QRS 150 ms ICD therapy is recommended for primary prevention of SCD in selected patients with HFrEF at least 40 days post-mi with LVEF 30%, and NYHA class I symptoms while receiving GDMT, who are expected to live 1 year* CRT can be useful for patients who have LVEF 35%, sinus rhythm, a non- LBBB pattern with a QRS 150 ms, and NYHA class III/ambulatory class IV symptoms on GDMT. CRT can be useful for patients who have LVEF 35%, sinus rhythm, LBBB with a QRS 120 to 149 ms, and NYHA class II, III or ambulatory IV symptoms on GDMT CRT can be useful in patients with AF and LVEF 35% on GDMT if a) the patient requires ventricular pacing or otherwise meets CRT criteria and b) AV nodal ablation or rate control allows near 100% ventricular pacing with CRT I I IIa IIa IIa A (NYHA class III/IV) B (NYHA class II) B A B B
29 Medical Management: the NPs Volume evaluation Orthostatic vitals Oral diuretic titration IV Diuresis METs back-up 29
30 HFC Case Study: Urgent diuresis 54 yo AfAm female NICM, EF 10%, C Cath in past yr neg for CAD. Na indiscretion at Memorial Day picnic - presents with dyspnea, PND, orthopnea, abd bloating, 11 lb wt gain VS: HR 120s, BP 90/60, RR 30s, O2 sat 88% PE: CV: S1S2 rapid, regular (ST on monitor), JVD 10 cm Pulm: fine crackles ½ way up bilat Abd: distended, hepatomegaly Ext: 2+ pitting edema to the knee 30
31 HFC Case Study: Urgent Diuresis Interventions IV/O2/ Monitor Stat labs (BUN/creat stable, K 3.6, BNP 2400) Lasix 80 mg IV x1, Kdur 40 meq po x1 3 hours later, 1900 ccs out, sig symptom relief, HR 90s, BP 100/70s, O2 sat 94% on RA Increased home diuretic, saw again early the next week, wt down 8 lbs, BUN/ creat stable. Feeling much better Admission averted! If our patients show up in any ER, they re getting admitted. We have to keep them out! Kabir Yousuf, MD 31
32 Medical Management: the NPs Ensuring treatment for pertinent co-morbid conditions, referring to appropriate specialists CAD Hypertension now thought to be #1 driver HF Pulmonary HTN Sleep apnea Afib, VT, other cardiac arrhythmias COPD Endocrine disorders diabetes, thyroid AICD and Pacemaker management/ SCA risk 32
33 Medical Management: the NPs Evaluate for worsening prognostic indicators Multiple exacerbations/ hospitalizations - >2 in one year Diuretic Resistance/ High diuretic requirement Hypotension resulting in d/c of core heart failure medications Hyponatremia Elevated BUN Cardiac cachexia Multiple AICD shocks or worsening arrhythmias Referral advanced therapeutics (LVAD, transplant) or palliative care/ hospice 33
34 Transitions of Care in Heart Failure: A Scientific Statement from the American Heart Association Registered nurses are leaders in delivering patient self-care education; however, the level of nurse understanding of chronic HF self-care principles must match patient needs. Albert, NM et al. Transitions of care in heart failure: A scientific statement from the American Heart Association. Circ Heart Fail. 2015; 8: DOI: /HHF
35 Heart Failure Teaching: the RNs AAHFN Certification Individually tailored to patients needs, interests, health literacy level Best of AHA, ACC, also interactive/ home grown education Videos made in HFC Self Management Education 35
36 Heart Failure Teaching: the RNs Engaging and Activating patients in Self-Care Daily weights fluid is heavy Symptom Recognition DOE/SOB Fatigue, activity intolerance LE and Abd edema PND/orthopnea 36
37 Heart Failure Teaching: the RNs Engaging and Activating patients in Self-Care The Low Sodium Diet: Patient s first question, most significant anxiety What can I eat?? 37
38 Real world pitfalls, real world strategies 38
39 The good, the bad and the better 39
40 Heart Failure Teaching: the RNs Engaging and Activating patients in Self-Care Medication Management 40
41 Case study: Pill boxing prevents readmissions 80 year old AfAm man, h/o NICM, EF 40%, HTN, Afib, diabetes, dementia 5 admissions between June 2013 August 2013 Admit 1: Hypoglycemia, Afib RVR Admit 2: Digoxin toxicity Admit 3: Syncope, hypoglycemia, Afib RVR Admit 4: *CHF exacerbation*, hypoglycemia Admit 5: Hypoglycemia (5 days after discharge patient s insulin finally stopped this admission) Admit 4 is index heart failure admission. Admit 5 is 30 day readmit patient referred to HFC. 41
42 Case Study: Pill boxing prevents readmissions First visit at 2 pm patient hasn t taken any medications nurses give pill boxes, explain how to use. Patient stable on all medications seen for minor medication adjustments over the next year. Wife has a CVA. Presents 4 times over a period of 2 months in worsening heart failure, requiring oral diuretic adjustment. Nurses have him bring in medications find he is not on furosemide doesn t have the bottle Nurses offer to assist with pill boxing. 42
43 Case Study: Pill boxing prevents readmissions Bi weekly help with pill boxing instituted Nurses supervise patient filling box, ensure all prescriptions filled as ordered. Nurses observe patient sometimes misses medications recommend change to long acting medications. Patient now rarely misses medications, no further HF exacerbations, despite occasional dietary indiscretions. 43
44 Heart Failure Teaching: the RNs Engaging and Activating patients in Self-Care Activity Progression Gentle ROM Walking program Thera - bands Cardiac Rehabilitation 44
45 Heart Failure Teaching: the RNs Engaging and Activating patients in Self-Care Time for a little controversy Fluid restrictions are not for everyone! per 2013 ACC/AHA Guidelines Only for Stage D or patients with Hyponatremia 45
46 Admission Prevention The whole team! Phone Triage early symptom recognition/ managing diuretics Urgent in-clinic diuresis Pill boxing a stabilizing force for select patients Palliative Care, referrals HU Task Force Care Plans And now - ED to HFC Admit Prevention 46
47 Palliative Care Why so important in Heart Failure? 50 % of ALL readmissions happen in the last two months of patient s lives 47
48 Palliative Care: the HFC approach Advance Care Planning videos grant from the Saint Agnes Foundation Courageous Conversations staff trainings, relationship with Gilcrest Hospice Our chaplain, the wonderful Sister Louise Busby Palliative diuresis and inotrope therapy 48
49 Our results patient satisfaction The Heart Failure Center staff helps me take my medications properly. 92.9% Agree Strongly * The Heart Failure Center helps me understand how to eat a low sodium diet. 92.9% Agree Strongly 7.1% Agree Somewhat The Heart Failure Center has helped me stay out of the hospital. 85.7% Agree Strongly * 7.1% Agree Somewhat The Heart Failure Center has improved my quality of life. 78.6% Agree Strongly * 14.3% Agree Somewhat I find it easy to get my appointments at the Heart Failure Center. 85.7% Agree Strongly 14.3% Agree Somewhat The staff members at the Heart Failure Center care about my well being. 100% Agree Strongly 49
50 Our results The HFC net promoter score 100% of respondents would recommend us to family and friends. I really LOVE the staff; friendly and caring! 50
51 Our results Patient Quality of Life Minnesota Living With Heart Failure Score Measurement of Quality of Life and symptom burden. Scores from 0 105, with 105 being worst QOL and symptom burden 69% of patients saw an improvement Average improvement of 35 points 51
52 Maybe our results? So many current interventions however Heart Failure readmissions down at St Agnes Nation-wide readmission numbers ~ 30% Saint Agnes Heart Failure readmission ~ 15.86% July 2016: 5.1% readmission rate! 52
53 Future directions COPD - HFC Model, staffed with RTs, NP Positive patient engagement Seasonal calls to patients Patient rewards program Trauma informed care Camden Model Motivational Interviewing Acceptance/nonjudgement 53
54 Want more Heart Failure Education? 54
55
56 Thank you! Questions / Comments Jill.patton@stagnes.org 56 October 3, 2016
2016 Update to Heart Failure Clinical Practice Guidelines
2016 Update to Heart Failure Clinical Practice Guidelines Mitchell T. Saltzberg, MD, FACC, FAHA, FHFSA Medical Director of Advanced Heart Failure Froedtert & Medical College of Wisconsin Stages, Phenotypes
More informationCongestive Heart Failure: Outpatient Management
The Chattanooga Heart Institute Cardiovascular Symposium Congestive Heart Failure: Outpatient Management E. Philip Lehman MD, MPP Disclosure No financial disclosures. Objectives Evidence-based therapy
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationEstimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches
Heart Failure: Management of a Chronic Disease Jenny Bauerly RN, CHFN, APRN-BC Heart Failure (HF) Definition A complex clinical syndrome that can result from any structural or functional cardiac disorder
More informationManagement Strategies for Advanced Heart Failure
Management Strategies for Advanced Heart Failure Mary Norine Walsh, MD, FACC Medical Director, HF and Cardiac Transplantation St Vincent Heart Indianapolis, IN USA President American College of Cardiology
More informationHeart Failure. Disclosures. Objectives: 8/28/2017. This is not a virus. It doesn t go away. none
Heart Failure This is not a virus. It doesn t go away Shelley Wojtaszczyk, FNP-C, CHFN Heart Failure Program Coordinator Mercy Hospital of Buffalo none Disclosures Objectives: Defining and identifying
More informationCitation. What is New in the 2013 ACC/AHA HF Guideline. Dimensions in Heart and Vascular Care Penn State Heart and Vascular Institute
What is New in the 2013 ACC/AHA HF Guideline Dimensions in Heart and Vascular Care Penn State Heart and Vascular nstitute Friday October 18, 2013 Barry S. Clemson, MD Associate Professor of Medicine Penn
More informationUpdate in Congestive Hear Failure DRAGOS VESBIANU MD
Update in Congestive Hear Failure DRAGOS VESBIANU MD Case 58 yo AAM c/o shortness of breath for 3 weeks. Used to walk one mile per day and now he has noticed that he gets short of breath after 2 blocks.
More informationSummary/Key Points Introduction
Summary/Key Points Introduction Scope of Heart Failure (HF) o 6.5 million Americans 20 years of age have HF o 960,000 new cases of HF diagnosed annually o 5-year survival rate for HF is ~50% Classification
More informationNew Advances in the Diagnosis and Management of Acute and Chronic Heart Failure
New Advances in the Diagnosis and Management of Acute and Chronic Heart Failure Deborah Budge, MD Intermountain Healthcare Heart Failure Cardiologist Objectives: State the updates from the ACC 2013 HF
More informationChronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.
Chronic Congestive^ Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center
More informationHeart Failure Guidelines For your Daily Practice
Heart Failure Guidelines For your Daily Practice Juan M. Aranda, Jr., MD, FACC, FHFSA Professor of Medicine Director of Heart Failure and Cardiac Transplantation University of Florida College of Medicine
More informationChronic. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Michael G. Shlipak, MD, MPH
Chronic Congestive^ Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center
More informationOptimizing CHF Therapy: The Role of Digoxin, Diuretics, and Aldosterone Antagonists
Optimizing CHF Therapy: The Role of Digoxin, Diuretics, and Aldosterone Antagonists Old Drugs for an Old Problem Jay Geoghagan, MD, FACC BHHI Primary Care Symposium February 28, 2014 None. Financial disclosures
More informationI have no disclosures. Disclosures
I have no disclosures Disclosures What is Heart Failure? Heart Failure (HF) A complex clinical syndrome where patients present with symptoms (i.e. dyspnea, fatigue, fluid retention) that result from any
More informationReducing 30-day Rehospitalization for Heart Failure: An Attainable Goal?
Reducing 30-day Rehospitalization for Heart Failure: An Attainable Goal? Ileana L. Piña, MD, MPH Professor of Medicine, Epi/Biostats Case Western Reserve University Graduate VA Quality Scholar Cleveland
More informationHFpEF. April 26, 2018
HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes
More informationHeart Failure 101 The Basic Principles of Diagnosis & Management
Heart Failure 101 The Basic Principles of Diagnosis & Management Bill Tran, MD Non Invasive Cardiologist February 24, 2018 What the eye does not see and the mind does not know, does not exist. DH Lawrence
More informationState-of-the-Art Management of Chronic Systolic Heart Failure
State-of-the-Art Management of Chronic Systolic Heart Failure Michael McCulloch, MD 17 th Annual Cardiovascular Update Intermountain Medical Center December 16, 2017 Disclosures: I have no financial disclosures
More informationThe ACC Heart Failure Guidelines
The ACC Heart Failure Guidelines Fakhr Alayoubi, Msc,R Ph President of SCCP Cardiology Clinical Pharmacist Assistant Professor At King Saud University King Khalid University Hospital Riyadh-KSA 2017 ACC/AHA/HFSA
More informationCLINICAL PRACTICE GUIDELINE
CLINICAL PRACTICE GUIDELINE Procedure: Congestive Heart Failure Guideline Review Cycle: Biennial Reviewed By: Amish Purohit, MD, MHA, CPE, FACHE Review Date: November 2014 Committee Approval Date: 11/12/2014
More informationGina G. Mentzer, MD Cardiologist, Heart Failure & Transplant Advanced Integrated Medicine & Surgery (AIMS) Program for Heart Failure April 18 th,
Gina G. Mentzer, MD Cardiologist, Heart Failure & Transplant Advanced Integrated Medicine & Surgery (AIMS) Program for Heart Failure April 18 th, 2015 Heart Failure (HF) Describe the natural course of
More informationHeart Failure: Guideline-Directed Management and Therapy
Heart Failure: Guideline-Directed Management and Therapy Guideline-Directed Management and Therapy (GDMT) was developed by the American College of Cardiology and American Heart Association to define the
More informationESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response
More informationOutline. Chronic Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.
Chronic Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center Scientific
More informationWHAT IS ADVANCED HEART FAILURE? James C. Fang, MD, FACC Professor and Chief Cardiovascular Division University of Utah School of Medicine
WHAT IS ADVANCED HEART FAILURE? James C. Fang, MD, FACC Professor and Chief Cardiovascular Division University of Utah School of Medicine Disclosures Data Safety Monitoring Board SOPRANO (J&J), EVALUATE-HF
More informationHeart Failure Management. Waleed AlHabeeb, MD, MHA Assistant Professor of Medicine Consultant Heart Failure Cardiologist
Heart Failure Management Waleed AlHabeeb, MD, MHA Assistant Professor of Medicine Consultant Heart Failure Cardiologist Heart failure prevalence is expected to continue to increase¹ 21 MILLION ADULTS WORLDWIDE
More informationDISCLOSURES ACHIEVING SUCCESS THROUGH FAILURE: UPDATE ON HEART FAILURE WITH PRESERVED EJECTION FRACTION NONE
ACHIEVING SUCCESS THROUGH FAILURE: UPDATE ON HEART FAILURE WITH PRESERVED EJECTION FRACTION Lori M. Tam, MD Providence Heart Institute DISCLOSURES NONE 1 OUTLINE Systolic vs. Diastolic Heart Failure New
More information2 I. Reduced EF (HFrEF)
HF Classification EF Description 2 I. Reduced EF (HFrEF) 40% 1. Referred to as systolic HF. 2. Randomized trials mainly enrolled patients with HFrEF. 3. Efficacious therapies is shown only in these patients.
More informationHEART FAILURE: PHARMACOTHERAPY UPDATE
HEART FAILURE: PHARMACOTHERAPY UPDATE 3 HEART FAILURE REVIEW 1 5.1 million x1.25 = 6.375 million 40 years old = MICHAEL F. AKERS, PHARM.D. CLINICAL PHARMACIST CENTRACARE HEALTH, ST. CLOUD HOSPITAL HF Diagnosis
More informationUpdates in Congestive Heart Failure
Updates in Congestive Heart Failure GREGORY YOST, DO JOHNSTOWN CARDIOVASCULAR ASSOCIATES 1/28/2018 Disclosures Edwards speaker on Sapien3 valves (TAVR) Stages A-D and NYHA Classes I-IV Stage A: High risk
More informationDisclosures. Advances in Chronic Heart Failure Management 6/12/2017. Van N Selby, MD UCSF Advanced Heart Failure Program June 19, 2017
Advances in Chronic Heart Failure Management Van N Selby, MD UCSF Advanced Heart Failure Program June 19, 2017 I have nothing to disclose Disclosures 1 Goal statement To review recently-approved therapies
More informationChronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology
Chronic Congestive^ Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center
More informationHeart Failure. Jay Shavadia
Heart Failure Jay Shavadia Definition Clinical syndrome characterized by: Symptoms: breathlessness at rest or on exercise, fatigue, tiredness or ankle swelling AND Signs: tachycardia, tachypnea, pulmonary
More informationThe CCS Heart Failure Companion: Bridging Guidelines to your Practice
The CCS Heart Failure Companion: Bridging Guidelines to your Practice Looking for practical answers concerning optimal heart failure care? The CCS Heart Failure Guidelines Companion can help. The Canadian
More informationDisclosures. Overview. Goal statement. Advances in Chronic Heart Failure Management 5/22/17
Disclosures Advances in Chronic Heart Failure Management I have nothing to disclose Van N Selby, MD UCSF Advanced Heart Failure Program May 22, 2017 Goal statement To review recently-approved therapies
More informationHeart Failure with Reduced EF. Dino Recchia, MD, FACC, FHFSA
Heart Failure with Reduced EF Dino Recchia, MD, FACC, FHFSA Heart Failure HF is the end phenotype of almost all CV disorders Complex clinical syndrome resulting from any structural or functional impairment
More informationHEART FAILURE IN WOMEN. Marian Limacher, MD Division of Cardiovascular Medicine University of Florida
HEART FAILURE IN WOMEN Marian Limacher, MD Division of Cardiovascular Medicine University of Florida Outline Epidemiology Clinical Overview Why HF is such a challenge State of the Field Heart Failure Adjudication
More informationChronic. Outline. Congestive^ Heart Failure: Update on Effective Monitoring and Treatment. Heart Failure Epidemiology. Michael G.
Chronic Congestive^ Heart Failure: Update on Effective Monitoring and Treatment Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine, SFVA Medical Center
More informationHeart Failure Management Policy and Procedure Phase 1
1301 Punchbowl Street, Harkness Suite 225 Honolulu, Hawaii 96813 Phone (808) 691-7220 Fax: (808) 691-4099 www.queenscipn.org Policy and Procedure Phase 1 Policy Number: Effective Date: Revised: Approved
More informationHEART FAILURE. Heart Failure in the US. Heart Failure (HF) 3/2/2014
HEART FAILURE Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center March 2014 Heart Failure in the US Prevalence - ~5 million 650,000 new cases annually 300,000 deaths annually Leading
More informationThe Failing Heart in Primary Care
The Failing Heart in Primary Care Hamid Ikram How fares the Heart Failure Epidemic? 4357 patients, 57% women, mean age 74 years HFSA 2010 Practice Guideline (3.1) Heart Failure Prevention A careful and
More information1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?
Disclosure Heart Failure Guideline Review and Update I have had no financial relationship over the past 12 months with any commercial sponsor with a vested interest in this presentation. Natalie Beiter,
More informationHeart Failure Update. Bibiana Cujec MD May 2015
Heart Failure Update Bibiana Cujec MD May 2015 Disclosures Participation in clinical trial GUIDE IT (BNP in management of HF) Plan Review of new trials/ccs guidelines Management of heart failure: cases
More information2/3/2017. Objectives. Effective Heart Failure Management through Evidence Based Practice and Innovation
Effective Heart Failure Management through Evidence Based Practice and Innovation Jennifer Bauerly RN, CHFN, APRN-BC CentraCare Heart and Vascular Center Objectives Describe the scope and impact of heart
More informationAll in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, MFMER
ICD for NICM All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, 2017 2017 MFMER 3686275-1 DISCLOSURE Relevant Financial Relationship(s)
More informationHeart Failure Therapies State of the Art: 2018
Heart Failure Therapies State of the Art: 2018 Andrew J. Sauer MD Associate Professor of Medicine Division Director Advanced Heart Failure Therapies & Cardiac Transplantation University of Kansas Medical
More informationCASE STUDIES IN ADVANCED HEART FAILURE
CASE STUDIES IN ADVANCED HEART FAILURE Navin Rajagopalan, MD Director, Congestive Heart Failure Medical Director, Cardiac Transplantation Gill Heart Institute, Cardiovascular Medicine DISCLOSURES NOTHING
More informationFINANCIAL DISCLOSURE: No relevant financial relationship exists
The Value of Guideline Directed Medical Therapy in Heart Failure Steve Dentel RN BSN CPHQ National Director, Field Programs and Integration American Heart Association/American Stroke Association FINANCIAL
More informationLong-Term Care Updates
Long-Term Care Updates July 2015 By Amy Friedman Wilson, PharmD Heart failure (HF) is a clinical condition in which ventricular filling or ejection of blood is structurally or functionally impaired. 1
More informationThe Role of Palliative Care in the Management of Advanced Heart Failure
Disclosure The Role of Palliative Care in the Management of Advanced Heart Failure I have no conflict of interest to disclose. Darrell Craig MD Medical Director, Palliative Care Services St. Joseph Mercy
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationHeart Failure, Anticoagulants, and Medication Reconciliation
Change in Condition: Heart Failure, Anticoagulants, and Medication Reconciliation Lindsay Holland, MHA Director, Care Transitions Health Services Advisory Group (HSAG) Pouya Afshar, MD, MBA Hospitalist,
More informationEvolution of Heart Failure Disease Management at a Large VA Medical Center. Richard S. Schofield MD, FACC North Florida/South Georgia VHS
Evolution of Heart Failure Disease Management at a Large VA Medical Center Richard S. Schofield MD, FACC North Florida/South Georgia VHS Disclosures None 2 1,000,000 Increasing VA Burden: Outpatient Encounters
More information3/2/2017. Identifying the Patient for Advanced Therapies. Why is Identifying the Adv HF patient important? CHF Stages and Steps of Treatment
Identifying the Patient for Advanced Therapies Cindy Bither Chief NP- Adv HF Program Medstar Heart and Vascular Institute Stage A High risk with no symptoms Stage B Structural heart disease, no symptoms
More informationChecklist for Treating Heart Failure. Alan M. Kaneshige MD, FACC, FASE Oklahoma Heart Institute
Checklist for Treating Heart Failure Alan M. Kaneshige MD, FACC, FASE Oklahoma Heart Institute Novartis Disclosure Heart Failure (HF) a complex clinical syndrome that arises secondary to abnormalities
More informationCase (Coding Nightmare) Current Dilemmas in Heart Failure : Closing the Gap between Clinical Care and Coding. Current Dilemmas in Heart Failure :
Current Dilemmas in Heart Failure : Closing the Gap between Clinical Care and Coding Interim Vice Chair for Clinical Affairs Department of Medicine, University of Florida 1 2 Case (Coding Nightmare) 69
More informationICD deactivation Patient Journey
ICD deactivation Patient Journey Julia decourcey Consultant Nurse Kings College Hospital 05.05.10 Internal Cardiac Defibrillator Used in pts at high risk of sudden cardiac death ie EF > 30% Previous survivor
More information2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure Developed in Collaboration With the American Academy of Family Physicians, American College of Chest
More informationWhat s new in heart failure management? Yonsei Cardiovascular Center Yonsei University College of Medicine
What s new in heart failure management? Yonsei Cardiovascular Center Yonsei University College of Medicine Current Guideline of Treatment Asymptomatic Mild/Mod Severe Refractory Correct Cause: Arrhythmias
More informationCRT Vs RV Pacing Benefits
CRT-P & CRT-D Indications According to Guidelines are Guidelines Fully Adopted? Salama H. Omar M.D. Prof. Critical Care Medicine, Cairo University CRT Vs RV Pacing Benefits 1 Benefit of Upgrade CTR-P &
More informationTaking the FAILURE out of CHF Denzil Moraes, MD, FACC
Taking the FAILURE out of CHF Denzil Moraes, MD, FACC Our Lady of the Lake Heart & Vascular Institute CHAIR Heart Failure Committee The Burden of Heart Failure Prevalence of Heart Failure ~ Currently 5.7
More informationNCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT
NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT CONTENTS PATIENTS ADMITTED WITH HEART FAILURE...4 Demographics... 4 Trends in Symptoms... 4 Causes and Comorbidities
More informationInitiating New Medications in the Management of Heart Failure
Initiating New Medications in the Management of Heart Failure Sandra Oliver-McNeil DNP, MSN, ACNP-BC, CHFN Associate Professor (Clinical) Wayne State University College of Nursing Objectives The participant
More information2017 CCS HF Guidelines Medical Therapy for HFrEF When What Order and How Much?
2017 CCS HF Guidelines Medical Therapy for HFrEF When What Order and How Much? Dr. Shelley Zieroth University of Manitoba @ShelleyZieroth @CanHFSociety Disclosures Consulting/Advisory Board: Amgen, Astra
More informationHeart Failure Background, recognition, diagnosis and management
Heart Failure Background, recognition, diagnosis and management Speaker bureau: Novartis At the conclusion of this activity, participants will be able to: Recognize signs and symptoms of heart failure
More informationHeart Failure A Team Approach Background, recognition, diagnosis and management
Heart Failure A Team Approach Background, recognition, diagnosis and management Speaker bureau: Novartis At the conclusion of this activity, participants will be able to: Recognize signs and symptoms of
More informationDisclosures. Objectives. What is Heart Failure? Best Practices for Managing Patients
Disclosures Best Practices for Managing Patients with Advanced Heart Failure I have no financial disclosures Site PI for observational heart failure study sponsored by Thoratec James O. Mudd, MD Assistant
More informationTherapeutic Targets and Interventions
Therapeutic Targets and Interventions Ali Valika, MD, FACC Advanced Heart Failure and Pulmonary Hypertension Advocate Medical Group Midwest Heart Foundation Disclosures: 1. Novartis: Speaker Honorarium
More informationESC Guidelines. ESC Guidelines Update For internal training purpose. European Heart Journal, doi: /eurheart/ehn309
ESC Guidelines Update 2008 ESC Guidelines Heart failure update 2008 For internal training purpose. 0 Agenda Introduction Classes of recommendations Level of evidence Treatment algorithm Changes to ESC
More informationSaudi Heart Failure Guidelines. Waleed AlHabeeb, MD, MHA Consultant Heart Failure Cardiologist President of the Saudi Heart Failure Group
Saudi Heart Failure Guidelines Waleed AlHabeeb, MD, MHA Consultant Heart Failure Cardiologist President of the Saudi Heart Failure Group Heart Failure Expert committee The Heart Failure Expert Committee,
More informationPalliative Care in Advanced CHF. Dina R. Yazmajian, MD Division of Cardiology Division of Palliative Care
Palliative Care in Advanced CHF Dina R. Yazmajian, MD Division of Cardiology Division of Palliative Care Required Disclosure Slide I have no financial or commercial interests which could result in any
More informationHEART FAILURE. Ali Mehr, MD, FACC
HEART FAILURE Ali Mehr, MD, FACC Advanced Heart Failure and Transplant Cardiologist Director, Echocardiography Lab Phoenix VA Health Care System Associate Professor of Medicine University of Arizona, COM,
More informationSusan P. D Anna MSN, APRN BC February 14, 2019
Is there Equal Opportunity in Heart Failure?? Susan P. D Anna MSN, APRN BC February 14, 2019 Disclosures: I have no financial disclosures. I am not an expert on this topic, but see a lot of women with
More informationNora Goldschlager, M.D. SFGH Division of Cardiology UCSF
CLASSIFICATION OF HEART FAILURE Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF DISCLOSURES: NONE CLASSIFICATION C OF HEART FAILURE NYHA I IV New paradigm Stage A: Pts at high risk of developing
More informationLITERATURE REVIEW: HEART FAILURE. Chief Residents
LITERATURE REVIEW: HEART FAILURE Chief Residents Heart Failure EF 40% HFrEF Problem with contractility EF 40-50% HFmrEF EF > 50% HFpEF Problem with filling/relaxation RISK FACTORS Post MI HTN DM Obesity
More informationHEART FAILURE KEEPING YOUR PATIENT AT HOME
HEART FAILURE KEEPING YOUR PATIENT AT HOME SUZANNE FRAZIER MS, CRNP, NP-C, CHFN HEART FAILURE DISEASE MANAGEMENT COORDINATOR PENN STATE HERSHEY HEART & VASCULAR INSTITUTE IMPACT OF HEART FAILURE In 2010,
More informationDisclosures. Preventing Heart Failure Re-admissions in Deaths Due to Cardiovascular Disease (United States: ) Heart Failure
29 th Annual Cardiology for Clinicians Spring Symposium Workshop #3 Alumni Hallway, Northeastern Conference Room, 1-9525 Thursday, May 5, 2016 Preventing Heart Failure Re-admissions in 2016 Leway Chen,
More informationDiagnosing Heart Failure in Primary Care: Differentiating Zebras from Horses
Diagnosing Heart Failure in Primary Care: Differentiating Zebras from Horses CANP March 2015 Maria Fe White, ACNP-BC Advanced Heart Disease Clinic Comprehensive Transplant Center Cedars-Sinai Medical Center
More informationVentricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation
Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation Objectives Current rationale behind use of MCS Patient Selection Earlier?
More informationHEART FAILURE. Heart Failure in the US. Heart Failure (HF) 10/5/2015. Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center
HEART FAILURE Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center Heart Failure in the US Prevalence - ~5 million 650,000 new cases annually 300,000 deaths annually Leading DRG among
More informationContemporary Management of Heart Failure. Keerthy K Narisetty, MD Comprehensive Heart Failure Management Program BHHI Primary Care Symposium
Contemporary Management of Heart Failure Keerthy K Narisetty, MD Comprehensive Heart Failure Management Program BHHI Primary Care Symposium Disclosures I have no relevant relationships with commercial
More informationThe Role of Exercise in Management of Patients with Heart Failure
The Role of Exercise in Management of Patients with Heart Failure Pamela B. Morris, MD, FACC, FAHA, FASPC, FNLA Chair, ACC Prevention of Cardiovascular Disease Leadership Council and Section Director,
More informationHeart Failure Clinician Guide JANUARY 2018
Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.
More informationCase 1. Case 2. What do you think about reducing or discontinuing some of the above now that his LVEF has normalized?
Case 1 A primary care colleague inquires what to do with a patient (HFrEF in NSR) who has a digoxin level of 2.8ng/ml. Level was obtained at 10am, patient takes all medications at one time upon arising
More informationHeart Failure. Dr. William Vosik. January, 2012
Heart Failure Dr. William Vosik January, 2012 Questions for clinicians to ask Is this heart failure? What is the underlying cause? What are the associated disease processes? Which evidence-based treatment
More informationImplementing the CardioMEMS HF System into the Management of Heart Failure Patients
Implementing the CardioMEMS HF System into the Management of Heart Failure Patients Robert W. Hull MD FACC Associate Professor of Medicine WVU Heart Institute Co-director, Arrhythmia Service Director,
More informationThe role of remote monitoring in preventing readmissions after acute heart failure
The role of remote monitoring in preventing readmissions after acute heart failure October 20, 2017 Randall C Starling MD MPH FACC FAHA FESA FHFSA Professor of Medicine Kaufman Center for Heart Failure
More informationHF QUALITY MEASURES. Hydralazine/nitrate at discharge: Percent of black heart
Get With The Guidelines - Heart Failure is the American Heart Association s collaborative quality improvement program, demonstrated to improve adherence to evidence-based care of patients hospitalized
More informationDevice Therapy for Heart Failure
Device Therapy for Heart Failure Dr. Shelley Zieroth FRCPC Assistant Professor, Cardiology, University of Manitoba Director of Cardiac Transplant and Heart Failure Clinics St Boniface General Hospital,
More informationHEART FAILURE. Heart Failure in the US. Heart Failure (HF) 2/20/2017. Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center
HEART FAILURE Martina Frost, PA-C Desert Cardiology of Tucson Northwest Medical Center Heart Failure in the US Prevalence - ~5 million 650,000 new cases annually 300,000 deaths annually Leading DRG among
More informationObjectives. Outline 4/3/2014
Jessica Litke PGY1 ISHP Spring Meeting April 12, 2014 Objectives Appreciate the significance of heart failure (HF) to a patient and to the health care system Understand 2013 ACCF/AHA guidelines for the
More informationHeart Failure Therapies State of the Art 2017
Heart Failure Therapies State of the Art 2017 Andrew J. Sauer, MD Assistant Professor Director, Center for Heart Failure Medical Director, Heart Transplantation UNOS Primary Transplant Physician asauer@kumc.edu
More informationCHF ICU to community. Disclosure slide CHF. Diagnosis. Diagnosis. Diagnostic modalties Therapeutic modalities. Talks. Advisory boards.
CHF ICU to community CHF Diagnostic modalties Therapeutic modalities ICU Pacer/ ICD Medication CHF clinic ASV - Nejm. Sept. 17,2015. Advanced care directives Disclosure slide Talks most companies Advisory
More informationDisclosures. This speaker has indicated there are no relevant financial relationships to be disclosed.
Disclosures This speaker has indicated there are no relevant financial relationships to be disclosed. And the Beat Goes On: New Medications for Heart Failure Alison M. Walton, PharmD, BCPS The Case of
More informationModule 1: Evidence-based Education for Health Care Professionals
Module 1: Evidence-based Education for Health Care Professionals Heart Failure is a HUGE Problem Prevalence Incidence Mortality Hospital Discharges Cost 1 5,300,000 660,000 284,965 1,084,000 $34.8 billion
More informationFrom PARADIGM-HF to Clinical Practice. Waleed AlHabeeb, MD, MHA Associate Professor of Medicine President of the Saudi Heart Failure Group
From PARADIGM-HF to Clinical Practice Waleed AlHabeeb, MD, MHA Associate Professor of Medicine President of the Saudi Heart Failure Group PARADIGM-HF: Inclusion Criteria Chronic HF NYHA FC II IV with LVEF
More informationIncidence. 4.8 million in the United States. 400,000 new cases/year. 20 million patients with asymptomatic LV dysfunction
Heart Failure Diagnosis According to the Working Group in Heart Failure, CHF is a syndrome where the diagnosis has the following essential components: A combination of: Symptoms, typically breathlessness
More informationUPDATES IN MANAGEMENT OF HF
UPDATES IN MANAGEMENT OF HF Jennifer R Brown MD, MS Heart Failure Specialist Medstar Cardiology Associates DC ACP Meeting Fall 2017 Disclosures: speaker bureau for novartis speaker bureau for actelion
More information